GC32836
Naquotinib Mesylate
Also listed as Naquotinib mesylate (ASP8273)
Naquotinib mesylate (ASP8273) (ASP8273 mesylate) is an orally available, mutant-selective and irreversible EGFR inhibitor; with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR
ChemicalCAS1448237-05-5MW658.81FormulaC31H46N8O6S
- CAS number
- 1448237-05-5
- Molecular weight
- 658.81
- Formula
- C31H46N8O6S
- Solubility
- DMSO ： 12·5 mg/mL (18·97 mM)
- InChIKey
- ALDUQYYVQWGTMR-GJFSDDNBSA-N
- Catalogue number
- GC32836
- Brand
- GLPBIO
Computed properties PubChem CID 92135932 · TPSA 183 Ų · H-bond donors 3 · H-bond acceptors 12
- TPSA
- 183 Ų
- H-bond donors
- 3
- H-bond acceptors
- 12
- Rotatable bonds
- 9
- Heavy atoms
- 46
SMILES CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C.CS(=O)(=O)O
Computed descriptors from PubChem (CID 92135932), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il